Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock, Common Stock and Stockholders??? Equity

v3.24.2.u1
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock, Common Stock and Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balances at beginning of period (in shares) at Dec. 31, 2022   35,571,000    
Balances at beginning of period at Dec. 31, 2022 $ 26,533 $ 4 $ 604,387 $ (577,858)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercise of stock options (in shares)   38,000    
Issuance of common stock upon exercise of stock options 71   71  
Shares issued in connection with the Employee Stock Purchase Plan (in shares)   100,000    
Shares issued in connection with the Employee Stock Purchase Plan 213   213  
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)   926,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings $ (1,272)   (1,272)  
Cancellation of Earn-Out Shares (in shares) (197,000)      
Reduction in transaction costs $ 9,609   9,609  
Payment in lieu of fractional shares in connection with reverse split (1)   (1)  
Stock-based compensation 9,924   9,924  
Net loss (23,936)     (23,936)
Balances at ending of period (in shares) at Jun. 30, 2023   36,438,000    
Balances at ending of period at Jun. 30, 2023 21,141 $ 4 622,931 (601,794)
Balances at beginning of period (in shares) at Mar. 31, 2023   35,749,000    
Balances at beginning of period at Mar. 31, 2023 27,700 $ 4 618,623 (590,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercise of stock options (in shares)   2,000    
Issuance of common stock upon exercise of stock options 3   3  
Shares issued in connection with the Employee Stock Purchase Plan (in shares)   100,000    
Shares issued in connection with the Employee Stock Purchase Plan 213   213  
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)   587,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (916)   (916)  
Payment in lieu of fractional shares in connection with reverse split (1)   (1)  
Stock-based compensation 5,009   5,009  
Net loss (10,867)     (10,867)
Balances at ending of period (in shares) at Jun. 30, 2023   36,438,000    
Balances at ending of period at Jun. 30, 2023 $ 21,141 $ 4 622,931 (601,794)
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2023 10,000      
Temporary equity, balances at beginning of period at Dec. 31, 2023 $ 10,000      
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2024 10,000      
Temporary equity, balances at ending of period at Jun. 30, 2024 $ 10,000      
Balances at beginning of period (in shares) at Dec. 31, 2023   37,908,000    
Balances at beginning of period at Dec. 31, 2023 $ 8,122 $ 4 629,208 (621,090)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercise of stock options (in shares) 6,762 7,000    
Issuance of common stock upon exercise of stock options $ 6   6  
Shares issued in connection with the Employee Stock Purchase Plan (in shares)   166,000    
Shares issued in connection with the Employee Stock Purchase Plan 235   235  
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)   872,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (795)   (795)  
Stock-based compensation 6,570   6,570  
Net loss (13,452)     (13,452)
Balances at ending of period (in shares) at Jun. 30, 2024   38,953,000    
Balances at ending of period at Jun. 30, 2024 $ 686 $ 4 635,224 (634,542)
Temporary equity, balances at beginning of period (in shares) at Mar. 31, 2024 10,000      
Temporary equity, balances at beginning of period at Mar. 31, 2024 $ 10,000      
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2024 10,000      
Temporary equity, balances at ending of period at Jun. 30, 2024 $ 10,000      
Balances at beginning of period (in shares) at Mar. 31, 2024   38,182,000    
Balances at beginning of period at Mar. 31, 2024 7,514 $ 4 631,991 (624,481)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercise of stock options (in shares)   7,000    
Issuance of common stock upon exercise of stock options 6   6  
Shares issued in connection with the Employee Stock Purchase Plan (in shares)   166,000    
Shares issued in connection with the Employee Stock Purchase Plan 235   235  
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)   598,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (414)   (414)  
Stock-based compensation 3,406   3,406  
Net loss (10,061)     (10,061)
Balances at ending of period (in shares) at Jun. 30, 2024   38,953,000    
Balances at ending of period at Jun. 30, 2024 $ 686 $ 4 $ 635,224 $ (634,542)